Ophtalmic Disorders

Review: Drugs that Induce Corneal Epithelial Changes

By December 05, 2016

Corneal epithelial changes can be caused by medications in multiple pharmacological classes.

AAO: Age-Related Macular Degeneration Risk Reduced with Mediterranean Diet

October 21, 2016

Eating a Mediterranean diet and consuming caffeine may lower the risk of age-related macular degeneration (AMD), according to a study presented at the annual meeting of the American Academy of Ophthalmology, held in Chicago.

Study Examines Topotecan-Based Therapy for Advanced Retinoblastoma

October 18, 2016

For patients with advanced retinoblastoma, topotecan combined with vincristine, carboplatin, and aggressive focal therapies is effective, according to a study published online in the Journal of Clinical Oncology.

FDA to Review Device-Based Approach for Tear Production

By July 18, 2016

Allergan announced the submission of a de novo application to the Food and Drug Administration (FDA) for the Oculeve Intranasal Tear Neurostimulator device.

Male to Female Corneal Transplants May Have Greater Rejection Risk

July 18, 2016

Women who undergo a corneal transplant may have a worse outcome if their donor is male, according to a study published online July 14 in the American Journal of Transplantation.

First-in-Class Eye Drops Approved to Treat Dry Eye Disease

By July 12, 2016

Shire announced that the Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5% for the treatment of the signs and symptoms of dry eye disease in adults. This is the first prescription ophthalmic solution approved to treat both signs and symptoms of this condition.

New Jetrea Formulation Eliminates Dilution Step

By June 08, 2016

ThromboGenics announced that the Food and Drug Administration (FDA) has approved a new "already-diluted" formulation of Jetrea (ocriplasmin) intravitreal injection.

Combigan Ophthalmic Solution Available in New Size

By June 02, 2016

Combigan (brimonidine tartrate, timolol maleate; Allergan) ophthalmic solution is now available in a new 15mL bottle size for a 90-day supply.

Number of Visually Impaired Americans Expected to Double by 2050

May 20, 2016

As baby boomers age, the number of Americans with visual impairment and blindness is expected to double over the next 3 decades, according to a study published online in JAMA Ophthalmology.

Antidepressant Linked to Increased IOP in Glaucoma Patient

May 09, 2016

In a case report published online April 30 in Clinical & Experimental Ophthalmology, venlafaxine-induced increase in intraocular pressure (IOP) is described in a patient with open angle glaucoma.

Eyeglass Device May Benefit Those With Low Vision

May 06, 2016

A device mounted onto eyeglasses enables people considered legally blind to "read" and perform other day-to-day activities, according to a study published online in JAMA Ophthalmology.